Loading...
Phase I study of everolimus and mitomycin C for patients with metastatic esophagogastric adenocarcinoma
This study aimed at determining the recommended dose of the mammalian target of rapamycin inhibitor everolimus in combination with mitomycin C (MMC) in patients with previously treated metastatic esophagogastric cancer. In this phase I trial, patients received escalated doses of oral everolimus (5,...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3699844/ https://ncbi.nlm.nih.gov/pubmed/23930209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.77 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|